WS #12081

From 500 msgs · 7 key-dev

Bloomberg reports OpenAI is working on an AI-powered speaker for release next year, sending Sonos shares down 3% after-hours. Celcuity announces FDA approval of REVTORPYK (gedatolisib) for HR+/HER2- breast cancer, a significant milestone for the company.

OpenAI AI Speaker Threatens Sonos

Bloomberg reports OpenAI is working on an AI-powered speaker for release next year, sending Sonos shares down 3% after-hours.

Celcuity announces FDA approval of REVTORPYK (gedatolisib) for HR+/HER2- breast cancer, a significant milestone for the company.

Full world state #12081 →